These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29965880)

  • 1. Nivolumab induced inflammation of seborrheic keratoses: a novel cutaneous manifestation in a metastatic melanoma patient.
    Rambhia PH; Honda K; Arbesman J
    Melanoma Res; 2018 Oct; 28(5):475-477. PubMed ID: 29965880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Verrucous melanoma masquerading as a seborrheic keratosis.
    Tran PT; Truong AK; Munday W; Alexanian S; Levins P
    Dermatol Online J; 2019 Feb; 25(2):. PubMed ID: 30865414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant melanoma arising in a seborrheic keratosis.
    Zabel RJ; Vinson RP; McCollough ML
    J Am Acad Dermatol; 2000 May; 42(5 Pt 1):831-3. PubMed ID: 10775864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seborrheic keratosis with trichilemmomas masquerading as melanoma.
    Burgess JT; Smith WB; Keeling JH
    Cutis; 1994 Nov; 54(5):351-3. PubMed ID: 7835066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melanoma within the seborrheic keratosis.
    Thomas I; Kihiczak NI; Rothenberg J; Ahmed S; Schwartz RA
    Dermatol Surg; 2004 Apr; 30(4 Pt 1):559-61. PubMed ID: 15056152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant melanoma simulating a seborrheic keratosis: a case report.
    Richert CA; Flynn KJ
    Dermatol Online J; 1997 Mar; 3(1):5. PubMed ID: 9141366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sign of Leser-Trélat associated with malignant melanoma.
    Fanti PA; Metri M; Patrizi A
    Cutis; 1989 Jul; 44(1):39-41. PubMed ID: 2752795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant neoplasms associated with seborrheic keratoses. An analysis of 54 cases.
    Cascajo CD; Reichel M; Sánchez JL
    Am J Dermatopathol; 1996 Jun; 18(3):278-82. PubMed ID: 8806962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation of seborrheic keratoses caused by cytarabine: a pseudo sign of Leser-Trelat.
    Patton T; Zirwas M; Nieland-Fisher N; Jukic D
    J Drugs Dermatol; 2004; 3(5):565-6. PubMed ID: 15552612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What can hide under exophytic verrucous appearance?
    de Giorgi V; Grazzini M; Savarese I; Rossari S; Gori A; Massi D; Lotti T
    Acta Derm Venereol; 2011 Jan; 91(1):100-1. PubMed ID: 21031279
    [No Abstract]   [Full Text] [Related]  

  • 11. Seborrheic keratosis-like melanoma.
    Salerni G; Alonso C; Gorosito M; Fernández-Bussy R
    J Am Acad Dermatol; 2015 Jan; 72(1 Suppl):S53-5. PubMed ID: 25500043
    [No Abstract]   [Full Text] [Related]  

  • 12. Painful acute thyroiditis following a first cure of Ipilimumab plus Nivolumab for metastatic melanoma.
    Montaudié H; Picard A; Panaia-Ferrari P; Boukari F; Passeron T; Sadoul JL; Brucker-Davis F
    Melanoma Res; 2018 Aug; 28(4):368-369. PubMed ID: 29916989
    [No Abstract]   [Full Text] [Related]  

  • 13. Not all lesions with a verrucous surface are seborrheic keratoses.
    Longo C; Moscarella E; Piana S; Lallas A; Carrera C; Pellacani G; Zalaudek I; Argenziano G
    J Am Acad Dermatol; 2014 Jun; 70(6):e121-3. PubMed ID: 24831328
    [No Abstract]   [Full Text] [Related]  

  • 14. Dermatoscopic Findings of Seborrheic Keratosis in Melanoma.
    Brandão ML; Oliveira Lima CM; Moura HH; Ishida C; Campos-do-Carmo G; Cuzzi T; Ramos-E-Silva M
    Acta Dermatovenerol Croat; 2016 Jun; 24(2):144-7. PubMed ID: 27477176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of anti-PD-1 therapy for metastatic melanoma and non-small-cell lung cancer in patients with viral hepatitis: a case series.
    Kothapalli A; Khattak MA
    Melanoma Res; 2018 Apr; 28(2):155-158. PubMed ID: 29406396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a biclonal cutaneous T-cell lymphoproliferative process during treatment with immune checkpoint inhibitors for metastatic melanoma.
    Davick JJ; Wick MR; Gru AA
    Melanoma Res; 2017 Aug; 27(4):383-386. PubMed ID: 28574977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete ophthalmoplegia in Ipilmumab and Nivolumab combination treatment for metastatic melanoma.
    Alnabulsi R; Hussain A; DeAngelis D
    Orbit; 2018 Oct; 37(5):381-384. PubMed ID: 29381409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seborrheic keratosis with basal clear cells: a distinctive microscopic mimic of melanoma in situ.
    Neuhaus IM; LeBoit PE; McCalmont TM
    J Am Acad Dermatol; 2006 Jan; 54(1):132-5. PubMed ID: 16384768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma mimicking seborrheic keratosis: an error of perception precluding correct dermoscopic diagnosis.
    Braga JC; Scope A; Klaz I; Mecca P; Spencer P; Marghoob AA
    J Am Acad Dermatol; 2008 May; 58(5):875-80. PubMed ID: 18328596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bullous Pemphigoid-like Skin Lesions and Overt Eosinophilia in a Patient With Melanoma Treated With Nivolumab: Case Report and Review of the Literature.
    Anastasopoulou A; Papaxoinis G; Diamantopoulos P; Christofidou E; Benopoulou O; Stratigos A; Gogas H
    J Immunother; 2018 Apr; 41(3):164-167. PubMed ID: 29309291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.